(Q43750138)

26 November 2017

title

Local side-effects of inhaled corticosteroids in asthmatic children: influence of drug, dose, age, and device (English)

1 reference

26 November 2017

0 references

J C Dubus

1

1 reference

26 November 2017

C Marguet

2

1 reference

26 November 2017

A Deschildre

3

1 reference

26 November 2017

L Mely

4

1 reference

26 November 2017

P Le Roux

5

1 reference

26 November 2017

J Brouard

6

1 reference

26 November 2017

L Huiart

7

1 reference

26 November 2017

Réseau de Recherche Clinique en Pneumonologie Pédiatrique

8

1 reference

26 November 2017

publication date

1 October 2001

1 reference

26 November 2017

number of pages

5

1 reference

inferred from page(s)

published in

Allergy

1 reference

26 November 2017

volume

56

1 reference

26 November 2017

issue

10

1 reference

26 November 2017

page(s)

944-948

1 reference

Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

Use of inhaled corticosteroids and the risk of cataracts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

Candidiasis and dysphonia complicating beclomethasone treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

Dysphonia caused by inhaled steroids: recognition of a characteristic laryngeal abnormality

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

Cough and wheezing from beclomethasone aerosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

Cough and wheezing from beclomethasone dipropionate aerosol are absent after triamcinolone acetonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

Clinical comparison of inhaled budesonide delivered either via pressurized metered dose inhaler or Turbuhaler

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

The incidence and significance of Staphylococcus aureus in respiratory cultures from patients infected with the human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

A 1-year comparison of turbuhaler vs pressurized metered-dose inhaler in asthmatic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

Inhaled beclomethasone and oral candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

Posterior subcapsular cataracts, bruises and hoarseness in children with asthma receiving long-term treatment with inhaled budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

Growth in asthmatic children treated with fluticasone propionate. Fluticasone Propionate Asthma Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

7 January 2021

Effect of inhaled corticosteroids on bones and growth

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

7 January 2021

Side effects of inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

7 January 2021

Early intervention for childhood asthma: inhaled glucocorticoids as the "preferred" medication

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

7 January 2021

Inhaled steroids in children: risks versus rewards

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

7 January 2021

Bronchial reactions to aerosol inhalant vehicle

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

7 January 2021

Local side-effects during 4-year treatment with inhaled corticosteroids--a comparison between pressurized metered-dose inhalers and Turbuhaler

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

7 January 2021

Comparison of the antiasthmatic, oropharyngeal, and systemic glucocorticoid effects of budesonide administered through a pressurized aerosol plus spacer or the Turbuhaler dry powder inhaler

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

7 January 2021

Hypertrophy of the tongue associated with inhaled corticosteroid therapy in premature infants

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

7 January 2021

Clinical adverse effects of inhaled corticosteroids: results of a questionnaire survey of asthma specialists

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

7 January 2021

Aerosol treatment of bronchoconstriction in children, with or without a tube spacer

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

7 January 2021

Growth of Candida albicans in Saliva: Stimulation by Glucose Associated with Antibiotics, Corticosteroids, and Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1034%2FJ.1398-9995.2001.00100.X

7 January 2021

10.1034/J.1398-9995.2001.00100.X

Identifiers

DOI

1 reference

26 November 2017

1 reference